However, at present, biliary tract cancer still depends on TNM staging to judge prognosis and lacks reliable molecular markers.[21]The prognostic value of tumor-infiltrating lymphocytes has attracted increasing attention in an increasing number of tumors, and other cells, except for FoxP3+Tregs, are worthy of further exploration. The gene discussed is FOXP3; the disease is biliary tract cancer.